Moreover, several studies have proven that inhibition of the NLRP3 inflammasome reduced tau aggregation and decreased the amyloid burden, which in turn diminished cognitive impairment in AD mice [18,19]. This evidence concerns the gene MAPT and Alzheimer disease.